ATBECHDEDKESFRGBGRITLILUNLSE..PTIE..................................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0828712A119980318EP95915993.01995051019971016enenen1998031819981219980318199812

C07D C I

A23K 1/ 16 A I

A61K 31/ 44 A I

A61K 31/ 505 A I

A61P 1/ 14 A I

A61P 3/ 00 A I

A61P 3/ 06 A I

A61P 3/ 08 A I

A61P 3/ 10 A I

A61P 11/ 00 A I

A61P 13/ 02 A I

A61P 15/ 00 A I

A61P 25/ 24 A I

A61P 25/ 26 A I

C07D 213/ 73 A I

C07D 213/ 74 A I

C07D 487/ 04 A I

C07F 7/ 10 A I

C07D 239/ 42 A N

enBETA-ADRENERGIC AGONISTSfrAGONISTES DU RECEPTEUR BETA-ADRENERGIQUEdeBETA-ADRENERGISCHE AGONISTENPFIZER INC.235 East 42nd StreetNew York, N.Y. 10017USDOW, Robert, L.132 Shore RoadWaterford, CT 06385USRuddock, Keith Stephen, et alPfizer Limited, European Patent Department, Ramsgate RoadSandwich, Kent CT13 9NJGBATBECHDEDKESFRGBGRIEITLILUNLPTSEIB199500034219950510enWO199603567019961114199650